Cibele Rodrigues Toledo

Cibele Rodrigues Toledo is a Researcher at the Institute for Quantitative Health Science & Engineering (IQ) within the College of Engineering at Michigan State University. Her work focuses on biomedical engineering, pharmaceutical sciences, and ophthalmology, with emphasis on drug delivery systems, nanomedicine, and theranostics. She has contributed to studies involving targeted radiopharmaceuticals, anti-angiogenic therapies, and novel treatments for ocular conditions like uveitis and endophthalmitis.

Her research integrates spider venom-derived peptides, nanoparticle formulations, and natural compounds (e.g., corosolic acid, lupeol) to address unmet clinical needs in ophthalmology. Recent work includes exploration of ketamine’s neuroprotective effects in retinal ischemia and vancomycin-loaded nanoparticles for bacterial endophthalmitis treatment. Toledo’s publications span 2017–2024, with a focus on translational applications of biomaterials and pharmacology.

While no explicit grants or awards are listed, her diverse publication portfolio reflects active involvement in collaborative, interdisciplinary research. Her lab affiliations include the IQ Health Science Institute, where she applies quantitative methods to biomedical challenges.